This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Cherng-Yih Perng: Innovator in Endothelin Receptor Antagonists
Introduction
Cherng-Yih Perng is a notable inventor based in Berwyn, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of endothelin receptor antagonists. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing healthcare.
Latest Patents
Cherng-Yih Perng holds a patent for a compound titled (E)-3-[1-n-Butyl-5-[2-(2-carboxyphenyl)methoxy-4-chlorophenyl]-1H-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-enoic acid monoargininyl salt. This invention relates to a new monoargininyl salt form of the endothelin receptor antagonist, which has potential therapeutic benefits.
Career Highlights
Cherng-Yih Perng is associated with SmithKline Beecham Corporation, where he has contributed to various research initiatives. His work in the pharmaceutical industry has been instrumental in developing new treatments and improving existing therapies.
Collaborations
Throughout his career, Cherng-Yih Perng has collaborated with notable colleagues, including Joseph Robert Flisak and Albert Stephen Kearney. These partnerships have fostered innovation and enhanced the research outcomes in their respective fields.
Conclusion
Cherng-Yih Perng's contributions to the field of pharmaceuticals, particularly through his patent on endothelin receptor antagonists, highlight his role as an innovator. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile